Inside IP Spring Summer 2017

Features a roundup of the latest cases and developments in IP.

40% increase in the number of European patents granted – A recent report revealed that the European Patent Office (EPO) granted a record number of European patents in 2016.  A 40% increase on 2015.  Siân Gill looks at the reasons behind the figures.

Nearly one year on – the new EPO opposition procedure – At the beginning of July 2016, the EPO introduced a new streamlined opposition procedure that is intended to simplify the opposition procedure and deliver decisions faster.  Tim Russell explores this. 

CRISPR – the IP battle – As advances in gene-editing technology are rapidly changing and making genome-edited human babies more of a possibility, Anton Hutter and Matt Handley look at the potential problems this could also bring.

IP audits: taking stock of your intellectual property – Anton Hutter and Catrin Petty look into the benefits of carrying out an Intellectual Property audit, explaining what audits are and discussing how to qualify for a financial contribution.

Playing the name game – David Yeomans discusses personal brands, registered trade marks and the dispute between Manchester United and Chelsea.

In Filmspeler, the CJEU signals a pragmatic approach to combatting online infringement – James Tumbridge and Robert Peake explain the recent decision relating to copyright infringement and the victory for copyright holders.

Update on plant patents at the EPO – Siân Gill provides an update on plant patents at the EPO following the notice issued by the EU Commission.

To opt out or not to opt out, that is the question – When the Unified Patent Court opens it will have jurisdiction over all European patents unless they have opted out.  Richard Kennedy looks at the benefits and risks associated with the new system.

G1/15: an antidote to poisonous priority and toxic divisionals – Ruth Shelton discusses the decision issued by the Enlarged Board of Appeal of the European Patent Office in case G1/15 clarifying how partial priority is to be assessed.

Arrow declarations.  Fujifim Kyowa Kirin Biologics Company Limited v Samsung Bioepsis UK Limited v AbbVie Biotechnology Limited – An ‘Arrow Declaration’ has been granted for the first time by the English High Court, allowing a product to go on the market despite facing patent applications which the product manufacturer cannot challenge.  Kate Woolhouse discusses.

Brexit Update – As Brexit continues to dominate the news, James Tumbridge provides an update.

Venner Shipley News

The Future Faces of the Automotive Industry – James Plunkett discusses the future of the automotive industry.

Standards essential and mandatory licensing – on what terms? – The High Court recently handed down judgment in a FRAND case, this is the first UK judgment to tackle the issue of how patent owners, who have patents which are essential to a standard, which everyone must follow, are expected to behave.  Ashley Roughton explains.

Disney’s fight to save registrations for its best-known characters – Cancellation actions were filed on the basis that Disney’s trade mark registration had not been used in the EU in five years immediately before the filing of the cancellation actions.  Yoann Fouquet looks at Disney’s fight to save its registrations.